ClinVar Miner

Submissions for variant NM_000218.3(KCNQ1):c.1096C>T (p.Arg366Trp) (rs199473411)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000045959 SCV000073972 pathogenic Long QT syndrome 2019-10-28 criteria provided, single submitter clinical testing This sequence change replaces arginine with tryptophan at codon 366 of the KCNQ1 protein (p.Arg366Trp). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is not present in population databases (ExAC no frequency). This variant has been reported in several individuals affected with long QT syndrome (PMID: 9693036, 15466642, 19716085, 19841300, 22949429, 24357532). ClinVar contains an entry for this variant (Variation ID: 52955). This variant identified in the KCNQ1 gene is located in the cytoplasmic C-terminal region of the resulting protein (PMID: 19841300, 25348405). For more information about the location of this variant, please visit Experimental studies have shown that this missense change impairs calmodulin binding and alters channel gating by generating a voltage-dependent slow inactivation (PMID: 16556865). Two additional missense substitutions at this codon (p.Arg366Pro, p.Arg366Gln) are reported to be deleterious (PMID: 9024139, 10973849, 16556865, 19934648). This indicates that the p.Arg366 residue is important for KCNQ1 protein function. For these reasons, this variant has been classified as Pathogenic.
GeneDx RCV000182173 SCV000234476 pathogenic not provided 2017-11-27 criteria provided, single submitter clinical testing The R366W variant has been published previously in several unrelated patients with LQTS, and was absent from >2,600 alleles from normal controls of at least of four different ethnic backgrounds (Choi G et al., 2004; Splawski I et al., 1998; Larsen LA et al., 1999; Kapplinger JD et al., 2009). Choi et al. (2004) reported the R366W variant in a 13 year-old female who presented with arrhythmias triggered by swimming (Choi G et al., 2004). Splawski et al. (1998) and Larsen et al. (1999) each observed this variant in one individual diagnosed with LQTS (Splawski I et al., 1998; Larsen LA et al., 1999), while Kapplinger et al. (2009) identified R366W in eight unrelated individuals in their cohort of LQTS patients (Kapplinger JD et al., 2009). In addition, this variant was not observed in 400 alleles from Caucasian and African American controls studied at GeneDx, thus further excluding the possibility that R366W is a common benign sequence variant. The NHLBI Exome Sequencing Project reports R366W was not observed in approximately 6,500 individuals from European and African American backgrounds. The R366W variant has been detected in other unrelated patients tested for LQTS at GeneDx.
HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology RCV000496023 SCV000584099 pathogenic Long QT syndrome 1 2015-02-10 criteria provided, single submitter research
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000057551 SCV000731642 likely pathogenic Congenital long QT syndrome 2017-07-24 criteria provided, single submitter clinical testing The p.Arg366Trp variant in KCNQ1 has been reported in >12 individuals with long QT syndrome (Splawski 1998, Choi 2004, Kapplinger 2009, Kapa 2009, Giudicessi 20 12, and Torekov 2014) and has also been reported by other clinical laboratories in ClinVar (Variation ID 52955). This variant was absent from large population s tudies. In vitro functional studies provide some evidence that the p.Arg366Trp v ariant may impact protein function (Shamgar 2006). Computational prediction tool s and conservation analysis suggest that this variant may impact the protein. In summary, although additional studies are required to fully establish its clinic al significance, the p.Arg366Trp variant meets criteria to be likely pathogenic for autosomal dominant long QT syndrome. ACMG/AMP Criteria applied: PM2, PS4_Mo derate, PS3_Supporting, PP3.
Ambry Genetics RCV000617196 SCV000737621 likely pathogenic Cardiovascular phenotype 2017-02-28 criteria provided, single submitter clinical testing Detected in individual satisfying established diagnostic critera for classic disease without a clear mutation;Rarity in general population databases (dbsnp, esp, 1000 genomes);In silico models in agreement (deleterious) and/or completely conserved position in appropriate species
Center for Human Genetics and Laboratory Diagnostics, Dr. Klein, Dr. Rost and Colleagues RCV000496023 SCV001422302 pathogenic Long QT syndrome 1 2020-01-16 criteria provided, single submitter clinical testing
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease,Montreal Heart Institute RCV000496023 SCV001433411 pathogenic Long QT syndrome 1 2020-02-25 criteria provided, single submitter clinical testing
Cardiovascular Biomedical Research Unit,Royal Brompton & Harefield NHS Foundation Trust RCV000057551 SCV000089070 not provided Congenital long QT syndrome no assertion provided literature only This variant has been reported as associated with Long QT syndrome in the following publications (PMID:9693036;PMID:10220146;PMID:11668638;PMID:14678125;PMID:15466642;PMID:15840476;PMID:16937190;PMID:19716085;PMID:19841300;PMID:10090529). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory.
Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare RCV000496023 SCV000863813 pathogenic Long QT syndrome 1 2018-02-19 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.